Related Experiment Videos
Systemically (but not intrathecally) administered IL-10 attenuates pathophysiologic alterations in experimental
U Koedel1, A Bernatowicz, K Frei
1Department of Neurology, Ludwig-Maximilians University of Munich, Klinikum Grosshadern, Germany.
Journal of Immunology (Baltimore, Md. : 1950)
|December 1, 1996
Summary
Interleukin-10 (IL-10) administration reduced inflammation and improved outcomes in a rat model of pneumococcal meningitis. Systemic IL-10 effectively mitigated key pathological markers, unlike local administration.
Area of Science:
- Neuroscience
- Immunology
- Infectious Diseases
Background:
- Bacterial meningitis involves complex pathophysiology, including inflammation and altered cerebral hemodynamics.
- Interleukin-10 (IL-10) is a potent immunosuppressive cytokine with potential roles in modulating inflammatory responses.
- The specific effects of IL-10 on the acute phase of pneumococcal meningitis remain incompletely understood.
Purpose of the Study:
- To investigate the therapeutic potential of Interleukin-10 (IL-10) in a rat model of pneumococcal meningitis.
- To evaluate the impact of IL-10 on key pathophysiological parameters, including cerebral blood flow, intracranial pressure, and inflammatory markers.
Main Methods:
- A rat model of pneumococcal meningitis was established via intracisternal (i.c.) challenge.
- Interleukin-10 (IL-10) was administered intraperitoneally (i.p.) or intracisternally (i.c.) at different dosages and time points.
- Regional cerebral blood flow, intracranial pressure, cerebrospinal fluid (CSF) white blood cell count, brain water content, IL-6, and nitrite levels were measured.
Main Results:
- Intraperitoneal administration of 5 µg of IL-10 significantly attenuated increases in regional cerebral blood flow, brain water content, intracranial pressure, and CSF white blood cell count.
- A lower dose (0.5 µg) of i.p. IL-10 was ineffective, and i.c. IL-10 administration did not modulate these parameters, even exacerbating CSF pleocytosis.
- Systemic IL-10 inhibited increases in CSF IL-6 levels and suppressed nitrite production in primary rat cerebral endothelial cells stimulated with pneumococci.
Conclusions:
- Systemic administration of Interleukin-10 (IL-10) demonstrates significant therapeutic potential in mitigating key pathological features of acute pneumococcal meningitis in rats.
- The beneficial effects of IL-10 appear to be route-dependent, with systemic administration being effective while local administration is not, and may involve modulation of IL-6 and nitric oxide pathways.